AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Juniper Genomics raises $4.6M in seed funding to advance its whole-genome embryo screening test, led by Company Ventures with participation from several other investors.

Jun 26, 2025•about 2 months ago

Amount Raised

$4.6 Million

Round Type

seed

TorontoBiotechnologyHealth Care

Investors

Blue CollectiveDria VenturesAmboy Street VenturesMbx CapitalInnospark VenturesCompany Ventures

Description

Juniper Genomics has launched with $4.6 million in seed funding to commercialize the first embryo screening test using whole genome and transcriptome sequencing. The funding will support commercial expansion, team growth, and ongoing research partnerships. The Canada-based company aims to establish a new clinical standard for IVF genetic testing. Company Ventures led the round, with participation from multiple other investors.

Company Information

Company

Juniper Genomics

Location

Toronto, Ontario, Canada

About

Juniper Genomics is a Canada-based company that has developed the first embryo screening test utilizing whole genome and transcriptome sequencing. The company aims to set a new clinical standard for IVF genetic testing by analyzing millions of genetic markers. Founded by a team of experts, Juniper focuses on specific genetic variants linked to adverse pregnancy outcomes rather than relying on polygenic risk scores. Their approach integrates seamlessly into existing IVF workflows, aiming to improve the success rate of embryo selection.

FundzWatch™ Score

Medium Activity

Related People

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers